BridgeBio Pharma, Inc. Banner Image

BridgeBio Pharma, Inc. has reached its limit for free report views

Work for BridgeBio Pharma, Inc.? Upgrade Your Profile and unlock all your annual reports.

BridgeBio Pharma, Inc.

  • Ticker BBIO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
BridgeBio Pharma, Inc. Logo Image
  • 201-500 Employees
  • Based in Palo Alto, California
BridgeBio is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. BridgeBio was founded in 2015 to identify and advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancersMore with clear genetic drivers. BridgeBio’s pipeline of over 20 development programs includes product candidates ranging from early discovery to late-stage development.
4.8 / 5.0 (108)

BridgeBio Pharma, Inc. reports have an aggregate usefulness score of 4.8 based on 108 reviews.

BridgeBio Pharma, Inc.

Most Recent Annual Report

BridgeBio Pharma, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Report Locked. BridgeBio Pharma, Inc. has reached its limit for free report views.

Older/Archived Annual Reports

BridgeBio Pharma, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!